"L'HUDERF est le seul hôpital belge exclusivement dédié aux enfants et aux adolescents. Il a pour missions de soigner et d'accompagner l'enfant, l'adolescent et ses proches, par une prise en charge globale, multidisciplinaire, humaniste et d'excellence; d'assurer un enseignement et une recherche de haut niveau par une démarche continue d'innovation et de développement des connaissances; et de contribuer activement à l'éducation à la santé. En mettant tout en oeuvre pour le bien-être de l'enfant, notre hôpital contribue à ce qu'il soit acteur de son propre développement et s'épanouisse dans la société."

During the past decade, Hôpital Universitaire des Enfants Reine Fabiola conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 14 clinical trials were completed, i.e. on average, 21.5% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 10 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Universitaire des Enfants Reine Fabiola" #1 sponsor was "Queen Fabiola Children's University Hospital" with 17 trials, followed by "Brugmann University Hospital" with 11 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Celgene" with 5 trials sponsored and "PTC Therapeutics" with 5 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Universitaire des Enfants Reine Fabiola" #1 collaborator was "Queen Fabiola Children's University Hospital" with 4 trials as a collaborator, "Australian & New Zealand Children's Haematology/Oncology Group" with 3 trials as a collaborator, "Cystic Fibrosis Foundation" with 3 trials as a collaborator, "Takeda Development Center Americas, Inc." with 3 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator. Other collaborators include 118 different institutions and companies that were collaborators in the rest 115 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Universitaire des Enfants Reine Fabiola" are "Cystic Fibrosis" (9 trials), "Crohn Disease" (7 trials), "Sickle Cell Disease" (7 trials), "Leukemia" (5 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "Hôpital Universitaire des Enfants Reine Fabiola" in a lesser frequency.

Most popular intervention types in "Hôpital Universitaire des Enfants Reine Fabiola" are "Drug" (56 trials), "Procedure" (15 trials), "Other" (13 trials), "Biological" (5 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ataluren" (4 trials), "Blood sampling" (4 trials), "cytarabine" (4 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Universitaire des Enfants Reine Fabiola" are 88 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 37 active trials in "Hôpital Universitaire des Enfants Reine Fabiola". 1 are not yet recruiting, 26 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 27 completed trials in Hôpital Universitaire des Enfants Reine Fabiola, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Universitaire des Enfants Reine Fabiola, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".